C79.10 ICD-10-CM Code: Secondary malignant neoplasm of unspecified urinary organs
C79.10 maps to CMS-HCC V28 18. A source-labeled RAF reference is available. Confirm the documented diagnosis and applicable coding requirements. MEAT criteria · RAF Calculator · HCC coding software
HCC Buddy Code Card
Digital ICD-10 code-book layout with official code detail, always-visible risk models, Code Trumping, and Buddy coding guidance.
FY 2026 Apr update / Neoplasms (C00-D49) / Malignant neoplasms of ill-defined, other secondary and unspecified sites (C76-C80)
C79.10
Billable / SpecificICD-10-CMOfficial ICD-10-CMCodebook guidanceSecondary malignant neoplasm of unspecified urinary organs
Cancer that has spread to the urinary system (kidneys, ureters, bladder, or urethra) but the specific organ location is not specified.
Buddy Insight
Secondary malignant neoplasm of unspecified urinary organs indicates metastatic cancer has spread to the urinary system but the specific organ (kidney, bladder, ureter, urethra) is not identified.
CMS-HCC V28
MappedHCC 18
Coefficient HCC 18: 2.341 (Community Non-Dual Aged (CNA))
CMS-HCC V24
HistoricalHistorical
Not used for CY2026 payment
ACA/HHS
MappedHCC 008
Code-level coefficient reference
ESRD/PACE
MappedHCC 8
Code-level coefficient reference
RXHCC
MappedHCC 18
Code-level coefficient reference
Code Book Path
Inclusion Terms
OfficialNo inclusion terms are included in this display for C79.10. Check the code and parent instructions in the Code Book.
Excludes 2
OfficialNo Excludes 2 notes are included in this display for C79.10. Check the code and parent instructions in the Code Book.
Related Codes
Includes
OfficialNo Includes notes are included in this display for C79.10. Check the code and parent instructions in the Code Book.
Excludes 1
Official- secondary carcinoid tumors (C7B.-)Inherited from C79
- secondary neuroendocrine tumors (C7B.-)Inherited from C79
Code First
OfficialNo Code First sequencing instructions are included in this display for C79.10. Check the code and parent instructions in the Code Book.
Use Additional
OfficialNo Use Additional Code instructions are included in this display for C79.10. Check the code and parent instructions in the Code Book.
Code Also
OfficialNo Code Also instructions are included in this display for C79.10. Check the code and parent instructions in the Code Book.
Buddy Documentation Tip
MEAT Support
Audit Caution
Common Mistakes
Current with CMS: FY2026 ICD-10-CM Apr 1 update (effective Apr 1 – Sep 30, 2026) · CMS-HCC V28, 100% phased in for payment year 2026. FY2027 code set already staged for October 1, 2026. How HCC Buddy stays current →
Is C79.10 an HCC code?
Yes. C79.10 (Secondary malignant neoplasm of unspecified urinary organs) maps to HCC 18, Cancer Metastatic to Bone, Other and Unspecified Metastatic Cancer; Acute Leukemia Except Myeloid under the CMS-HCC V28 risk adjustment model, with a source-labeled community non-dual aged reference coefficient of 2.341. Source-labeled code-level coefficients are references, not member totals. Actual contribution depends on complete member context, hierarchy and cleanup rules, interactions, and model year. HCC Buddy's RAF Calculator supports CMS-HCC V28 PY2026 and shows no score unless every required source and calculation check passes. It is billable for payment year 2026.
Coder answer: C79.10 is billable and maps to V28 HCC 18, Cancer Metastatic to Bone, Other and Unspecified Metastatic Cancer; Acute Leukemia Except Myeloid. Open it in the Code Book for the tabular path, RAF, and MEAT checklist.
- Code
- C79.10
- Description
- Secondary malignant neoplasm of unspecified urinary organs
- HCC (V28)
- HCC 18 — Cancer Metastatic to Bone, Other and Unspecified Metastatic Cancer; Acute Leukemia Except Myeloid
- RAF reference coefficient
- 2.341
- Billable
- Yes
- Payment year
- 2026
HCC Category Mapping
These are source-labeled model coefficients, not member totals. A category may still be removed by hierarchy or model cleanup rules. Weights are not directly comparable across models: CMS-HCC V28 and V24 use Community, Non-Dual, Aged; ESRD uses the dialysis continuing-enrollee model; RxHCC is the Part D continuing-enrollee, non-low-income, aged weight (a larger scale than CMS-HCC). ACA/HHS has no single weight — it varies by metal level. Actual per-patient RAF contribution depends on member context, hierarchy and cleanup rules, interactions, and the model year used by the payer. V28 is the CMS-HCC model phased in over payment years 2024–2026; V24 remains available for historical review.
Work C79.10 in the Code Book — tabular path, V28 RAF reference, and MEAT checklist →
MEAT review for C79.10
For C79.10, confirm that the documentation supports the diagnosis and meets the applicable coding, encounter, program and payer requirements. MEAT (Monitor, Evaluate, Assess, or Treat) is a review mnemonic, not a universal CMS coding rule.
- MMonitor: signs, symptoms, disease progression, or lab trending documented in the note
- EEvaluate: test results, medication response, or physical findings reviewed by the provider
- AAssess: explicit mention in the assessment or plan with acknowledgment of status
- TTreat: medication, referral, procedure, therapy, or counseling tied to the diagnosis
Coder workflow notes
Get the V28 mapping + MEAT cheat sheet
One printable reference: check representative V28 mappings and the documentation reminders your note needs. Free, no card.
Free PDF. No card. Unsubscribe anytime.
What This Code Means
C79.10 is the ICD-10-CM diagnosis code for secondary malignant neoplasm of unspecified urinary organs. Cancer that has spread to the urinary system (kidneys, ureters, bladder, or urethra) but the specific organ location is not specified. C79.10 sits in the ICD-10-CM chapter for neoplasms (c00-d49), within the section covering malignant neoplasms of ill-defined, other secondary and unspecified sites (c76-c80).
Under the CMS-HCC V28 risk adjustment model, C79.10 maps to Cancer Metastatic to Bone, Other and Unspecified Metastatic Cancer; Acute Leukemia Except Myeloid (HCC 18) with a source-labeled community, non-dual, aged reference coefficient of 2.341. For CY2026 non-PACE Medicare Advantage, CMS uses 100% of the 2024 CMS-HCC model (V28). PACE uses a separate model blend. Source-labeled code-level coefficients are references, not member totals. Actual contribution depends on complete member context, hierarchy and cleanup rules, interactions, and model year. HCC Buddy's RAF Calculator supports CMS-HCC V28 PY2026 and shows no score unless every required source and calculation check passes.
Use this code only when the specific urinary organ site cannot be determined; if location is known, use more specific codes (C79.01-C79.02 for kidney, C79.11 for bladder). For C79.10, confirm that the documentation supports the diagnosis and meets the applicable coding, encounter, program and payer requirements. MEAT (Monitor, Evaluate, Assess, or Treat) is a review mnemonic, not a universal CMS coding rule. When documentation is ambiguous, coders should issue a provider query rather than assume the highest-specificity variant.
HCC Buddy maintains structured V28 and V24 mapping, source-labeled coefficient references, and MEAT documentation criteria for C79.10 sourced directly from the CMS-HCC risk adjustment model files and the CMS ICD-10-CM code set.
Coding Tips
Clinical Significance
Secondary malignant neoplasm of unspecified urinary organs indicates metastatic cancer has spread to the urinary system but the specific organ (kidney, bladder, ureter, urethra) is not identified. This code reflects incomplete documentation and should trigger a provider query to identify the specific urinary organ involved for more precise coding.
Documentation Requirements
- ✓Primary cancer site documented and coded separately
- ✓Best available description of which urinary organ is involved
- ✓Provider query documenting attempt to clarify the specific urinary organ
- ✓Imaging or cystoscopic findings that may localize the metastatic site
- ✓Urinary symptoms — hematuria, obstruction, frequency changes
Commonly Confused Codes
- •C79.00-C79.02: Secondary malignant neoplasm of kidney; use kidney-specific codes when kidney is the documented site
- •C79.11: Secondary malignant neoplasm of bladder; use when bladder is specifically involved
- •C79.19: Secondary malignant neoplasm of other urinary organs; use when a specific non-kidney, non-bladder urinary organ is identified
- •C68.0-C68.9: Primary malignant neoplasm of other urinary organs; distinguish primary from secondary